acyclovir
Generic: acyclovir
Labeler: macleods pharmaceuticals limitedDrug Facts
Product Profile
Brand Name
acyclovir
Generic Name
acyclovir
Labeler
macleods pharmaceuticals limited
Dosage Form
OINTMENT
Routes
Active Ingredients
acyclovir 50 mg/g
Manufacturer
Identifiers & Regulatory
Product NDC
33342-439
Product ID
33342-439_49a1e24d-5821-45a5-bf2f-0497f4fd3a1b
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA212444
Listing Expiration
2026-12-31
Marketing Start
2018-08-13
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
33342439
Hyphenated Format
33342-439
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
acyclovir (source: ndc)
Generic Name
acyclovir (source: ndc)
Application Number
ANDA212444 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 50 mg/g
Packaging
- 1 TUBE in 1 CARTON (33342-439-15) / 15 g in 1 TUBE
- 1 TUBE in 1 CARTON (33342-439-30) / 30 g in 1 TUBE
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["TOPICAL"], "spl_id": "49a1e24d-5821-45a5-bf2f-0497f4fd3a1b", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "unii": ["X4HES1O11F"], "rxcui": ["197312"], "spl_set_id": ["d42fce5a-9ea3-4058-a3ba-4c18a6024160"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["Macleods Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 TUBE in 1 CARTON (33342-439-15) / 15 g in 1 TUBE", "package_ndc": "33342-439-15", "marketing_start_date": "20210805"}, {"sample": false, "description": "1 TUBE in 1 CARTON (33342-439-30) / 30 g in 1 TUBE", "package_ndc": "33342-439-30", "marketing_start_date": "20180813"}], "brand_name": "Acyclovir", "product_id": "33342-439_49a1e24d-5821-45a5-bf2f-0497f4fd3a1b", "dosage_form": "OINTMENT", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "33342-439", "generic_name": "Acyclovir", "labeler_name": "Macleods Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "50 mg/g"}], "application_number": "ANDA212444", "marketing_category": "ANDA", "marketing_start_date": "20180813", "listing_expiration_date": "20261231"}